These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5868192)

  • 1. [Fibrinogen content and fibrinolytic activity of the blood in nephropathy of pregnant women].
    Shteĭngauer VV
    Vopr Okhr Materin Det; 1965 Sep; 10(9):57-61. PubMed ID: 5868192
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal blood haemostatic-fibrinolytic balance and intrauterine growth retardation.
    Ylä-Outinen A; Tuimala R; Koivula T; Pystynen P
    Ann Chir Gynaecol Suppl; 1985; 197():43-5. PubMed ID: 3863530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzymatic and nonenzymatic fibrinolysis in various kidney diseases].
    Sokratov NV
    Ter Arkh; 1983; 55(6):55-8. PubMed ID: 6193598
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in recurrent miscarriage.
    Marchi R; López Ramirez Y; Nagaswami C; Masova L; Pulido A; López Mora J; Muller A; Arocha-Piñango CL; Weisel JW
    Thromb Haemost; 2007 Apr; 97(4):552-7. PubMed ID: 17393017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
    Kendić S; Mujezinović O; Muratović H
    Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercoagulability during pregnancy: evidences for a thrombophilic state].
    Maiello M; Torella M; Caserta L; Caserta R; Sessa M; Tagliaferri A; Bernacchi M; Napolitano M; Nappo C; De Lucia D; Panariello S
    Minerva Ginecol; 2006 Oct; 58(5):417-22. PubMed ID: 17006429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and management of hypercoagulation in obstetrical diseases].
    Suzuki S
    Rinsho Ketsueki; 1980 Jun; 21(6):751-8. PubMed ID: 7463735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of plasma fibrinolytic activity and blood fibrinogen level after interruption of early pregnancy].
    Rózewicki S
    Wiad Lek; 1969 Mar; 22(6):531-5. PubMed ID: 5788867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of the laboratory diagnosis of hypercoagulability].
    Vorlová Z; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum content of total protein and its fractions in pregnant women with nephropathy].
    Stepanova PA; Upit ZF
    Sov Med; 1974; 0(4):147-8. PubMed ID: 4838603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolysis in idiopathic renal hemorrhage].
    Ochiai K; Yokokawa M
    Kokubyo Gakkai Zasshi; 1967 Jun; 34(2):203-6. PubMed ID: 5235632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Different aspects of the defibrinization syndrome in gynecology-obstetrics].
    La Selve A; Le Petit JC; Vial JY; Brizard CP
    J Med Lyon; 1970 Jun; 51(188):1271-2 passim. PubMed ID: 5479123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of a combined analyzer-computer for evaluating blood fibrinolytic activity].
    Efimov VS; Kotov IuB; Grishin VL; Klimenko PA
    Lab Delo; 1985; (10):597-600. PubMed ID: 2416994
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in hemostasis and fibrinolysis in gestational diabetes].
    Kvasnicka J; Bendl J; Zivný J; Umlaufová A; Maslowská H
    Cas Lek Cesk; 1996 Feb; 135(4):106-10. PubMed ID: 8625379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.
    Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M
    Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation assessment by rotation thrombelastometry in normal pregnancy.
    Huissoud C; Carrabin N; Benchaib M; Fontaine O; Levrat A; Massignon D; Touzet S; Rudigoz RC; Berland M
    Thromb Haemost; 2009 Apr; 101(4):755-61. PubMed ID: 19350122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the fibrinolytic system during nonpregnant and pregnant oestrous cycles of bitches.
    Bunck CF; Mischke R; Günzel-Apel AR
    J Reprod Fertil Suppl; 2001; 57():207-14. PubMed ID: 11787151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haemocoagulative modifications correlated with pregnancy].
    Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
    Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.